NGM BIOPHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Jan 2024)
What this means for you
This application is over — abandoned 01 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97341658
- Mark type
- Stylized text
- Filed
- 31 Mar 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 01 Jan 2024
- Attorney of record
- Ilene B. Tannen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Owner
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 02 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 30 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Apr 2023 — PUBLISHED FOR OPPOSITION
- 15 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Aug 2022 — NON-FINAL ACTION E-MAILED
- 09 Aug 2022 — NON-FINAL ACTION WRITTEN
- 04 Aug 2022 — ASSIGNED TO EXAMINER
- 06 Apr 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED